DAS28-ESR | ||||||
---|---|---|---|---|---|---|
Remission (<2.6) | LDA (2.6 to ≤3.2) | MDA (3.2 to ≤5.2) | HDA >5.2 | Totals | ||
15.6% (n=4857) | 11.1% (n=3440) | 38.0% (n=11810) | 35.3% (n=10977) | 100% (31084) | ||
Remission (<2.6) | DAS28-CRP | 66.7% (4041) | 25.4% (1541) | 7.9% (481) | 0 | 19.5% (6063) |
mDAS28-CRP | 84.6% (2720) | 13.9% (446) | 1.6% (51) | 0 | 10.3% (3217) | |
LDA (2.6 to ≤3.2) | DAS28-CRP | 15.8% (646) | 32.0% (1303) | 52.2% (2128) | 0 | 13.1% (4077) |
mDAS28-CRP | 42.1% (1487) | 39.2% (1384) | 18.7% (662) | 0 | 11.4% (3533) | |
MDA (3.2 to ≤5.2) | DAS28-CRP | 1.4% (170) | 4.9% (591) | 73.7% (8881) | 20.0% (2414) | 38.8% (12056) |
mDAS28-CRP | 5.0% (650) | 12.3% (1601) | 76.5% (9916) | 6.4% (837) | 41.8% (13004) | |
HDA >5.2 | DAS28-CRP | 0 | 0.1% (5) | 3.6% (320) | 96.3% (8563) | 28.6% (8888) |
mDAS28-CRP | 0 | 0.1% (9) | 10.4% (1181) | 89.5% (10140) | 36.4% (11330) |
LDA, low disease activity; MDA, moderate disease activity; HDA, high disease activity.